COMMUNIQUÉS West-GlobeNewswire

Auxly Announces Definitive International Supply Agreement With Aphria

07/09/2018 - 14:55

VANCOUVER, British Columbia, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX - CBWTF) (" Auxly " or the " Company ") is pleased to announce that further to its previously announced [...]

Tabula Rasa HealthCare Announces TRHC 2.0: Innovative Integrations, Interoperability and Advanced Healthcare Analytics

07/09/2018 - 14:53

Through accretive acquisitions and continued research and development, TRHC’s technology innovations and growing data lake provide a data continuum for clients enhancing the care of patients across the U.S. and abroad [...]

Oryzon receives approval to begin REIMAGINE: a Phase IIa clinical trial with Vafidemstat (ORY-2001) in aggressiveness

07/09/2018 - 14:40

The approval has been granted by the Spanish Medicines Agency The study will be done in patients with 3 psychiatric disorders and 2 neurodegenerative disorders This is the first Phase IIa study with Vafidemstat (ORY- [...]

First Choice Healthcare Solutions Announces Appointment of Mr. James Renna, Dr. Thomas Gill and Mr. Gary Augusta to Board of Directors

07/09/2018 - 14:30

MELBOURNE, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]

Portola Pharmaceuticals Announces Executive Leadership Change

07/09/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Tao Fu, chief commercial officer, has resigned effective September 21, 2018 to pursue [...]

Sarepta Therapeutics to Recognize World Duchenne Awareness Day at NASDAQ Opening Bell Ceremony

07/09/2018 - 14:30

CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a global biopharmaceutical company focused on the discovery and development of precision genetic medicines for the [...]

Zealand Pharma to attend J.P. Morgan Cazenove and Morgan Stanley Global Healthcare Conferences

07/09/2018 - 14:18

Press release - No. 19 / 2018 Zealand Pharma to attend J.P. Morgan Cazenove and Morgan Stanley Global Healthcare Conferences Copenhagen, September 7, 2018 - Mats Blom, Executive Vice President and Chief Financial [...]

Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference

07/09/2018 - 14:00

BOSTON, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

The results of the migraine study will be delayed from the previously reported schedule

07/09/2018 - 14:00

Biohit Oyj Stock Exchange Release 07.09.2018 at 15:00 local time (EET) The results of the migraine study will be delayed from the autumn 2018 which was reported in Biohit’s Half Year Financial Report (H1 2018). In [...]

Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD

07/09/2018 - 13:30

Providing a best-in-class solution for immuno-oncology research, from RNA extraction to comprehensive data analysis, to advance therapeutic development SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- [...]

T2 Biosystems Reports Granting of Inducement Awards

07/09/2018 - 13:00

LEXINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Unum Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference

07/09/2018 - 13:00

CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

AxoGen to Participate at 73rd Annual American Society for Surgery of the Hand Meeting

07/09/2018 - 13:00

Outcomes data for more than 400 nerve repairs with Avance ® Nerve Graft will be reviewed at hosted symposium Data will highlight outcomes on sensory, mixed, motor, and long gap nerve repairs ALACHUA, Fla., Sept. 07, [...]

Tonix Pharmaceuticals Announces New Board Member, Oye Olukotun, M.D.

07/09/2018 - 13:00

NEW YORK, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) today announced the appointment of Adeoye “Oye” Olukotun, M.D. to its Board of Directors, effective immediately. Dr [...]

Emerald Health Therapeutics Confirms Supply Agreement with Ontario Cannabis Retail Corporation to Supply Adult-Use Cannabis Products

07/09/2018 - 13:00

VICTORIA, British Columbia, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that it has been selected as an approved supplier by the Ontario [...]

Align Technology Launches Treatment Planning Facility in Spain

07/09/2018 - 12:00

The newly opened facility will add 130 jobs in 2018, provide local support to Invisalign trained doctors in Spain and Portugal MADRID, Spain and SAN JOSE, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc [...]

HealthLynked Corp. Announces Release of Group Chat Functionality Allowing Patients to Discuss Healthcare Topics in Real-time with Other Patients and Healthcare Professionals

07/09/2018 - 11:00

NAPLES, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the release of its real-time chat software. HealthLynked’s new chat software allows its patient/users to join existing [...]

ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares

07/09/2018 - 10:21

LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA [...]

Management Board of JSC Olainfarm: Olainfarm will continue its development as intended by V. Maligins

07/09/2018 - 08:48

The Board of JSC "Olainfarm" informs that the newly elected company's Council and the Board constructively cooperate, and the first joint meeting took place already on September 4. The Council of the Company discussed [...]